Crossmark

The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease

Crossref DOI link: https://doi.org/10.1186/s12872-025-04768-8

Published Online: 2025-04-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haj Saleh, Nour

A. Youssef, Lama
Funding

Funding for this research was provided by:

The Ministry of Higher Education and Scientific Research-Fund to support scientific research and technological developmen
License Information

Text and Data Mining valid from 2025-04-28

Version of Record valid from 2025-04-28
More Information

Article History

Received: 24 January 2025

Accepted: 14 April 2025

First Online: 28 April 2025

Declarations

:

: The study protocol was approved by the Scientific Research Ethics Committee at the Faculty of Pharmacy, Damascus University in accordance with the Declaration of Helsinki (1964). All patients provided written informed consent.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below